These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 2825278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U, Udén R, Ahlbäck SO.
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantification of changes in bone scans of patients with osseous metastases of prostatic carcinoma.
    Prout GR, Griffin PP, Castronovo FP.
    Adv Exp Med Biol; 1992 Mar; 324():233-43. PubMed ID: 1492620
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distribution of skeletal metastases in prostatic and lung cancer. Mechanisms of skeletal metastases.
    Morgan JW, Adcock KA, Donohue RE.
    Urology; 1990 Jul; 36(1):31-4. PubMed ID: 2368229
    [Abstract] [Full Text] [Related]

  • 10. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
    Sundkvist GM, Ahlgren L, Lilja B, Mattsson S.
    Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
    [Abstract] [Full Text] [Related]

  • 11. Correlation of prostate-specific antigen and technetium-99m HMDP bone imaging.
    Shih WJ, Wierzbinski B, Collins J, Pearson TC, Magoun S, Ryo UY.
    Clin Nucl Med; 1989 Oct; 14(10):750-5. PubMed ID: 2478331
    [Abstract] [Full Text] [Related]

  • 12. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF, Wollett FC.
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Scintigraphic control of bone metastases of prostatic cancer treated with cytonal and cyclophosphamide].
    Grossmann J, Weiss M, Deckart H, Raatzsch H.
    Radiobiol Radiother (Berl); 1988 Nov; 29(6):736-8. PubMed ID: 3253797
    [No Abstract] [Full Text] [Related]

  • 16. [Bone scintigraphy and rhenium radioisotope management in the course of metastatic prostatic cancer].
    Ostwald E, Sabri O, Cremerius U, Jakse G, Büll U.
    Nuklearmedizin; 1999 Nov; 38(7):302-5. PubMed ID: 10599071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paget's disease mimicing skeletal metastases in a patient with coexisting prostatic carcinoma.
    Shih WJ, Riley C, Magoun S, Ryo UY.
    Eur J Nucl Med; 1988 Nov; 14(7-8):422-3. PubMed ID: 3181194
    [Abstract] [Full Text] [Related]

  • 19. Optimizing the performance and interpretation of bone scans.
    Muroff LR.
    Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.